- Home
- BACK vs PHIO Comparison
BACK vs PHIO Comparison
Compare BACK & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BACK
- PHIO
- Stock Information
- Founded
- BACK 2000
- PHIO 2011
- Country
- BACK United States
- PHIO United States
- Employees
- BACK N/A
- PHIO N/A
- Industry
- BACK Medical Specialities
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- BACK Health Care
- PHIO Health Care
- Exchange
- BACK Nasdaq
- PHIO Nasdaq
- Market Cap
- BACK 2.1M
- PHIO 2.3M
- IPO Year
- BACK 2019
- PHIO N/A
- Fundamental
- Price
- BACK $1.02
- PHIO $2.21
- Analyst Decision
- BACK
- PHIO Strong Buy
- Analyst Count
- BACK 0
- PHIO 1
- Target Price
- BACK N/A
- PHIO $36.00
- AVG Volume (30 Days)
- BACK 36.3K
- PHIO 41.4K
- Earning Date
- BACK 11-26-2024
- PHIO 11-14-2024
- Dividend Yield
- BACK N/A
- PHIO N/A
- EPS Growth
- BACK N/A
- PHIO N/A
- EPS
- BACK N/A
- PHIO N/A
- Revenue
- BACK N/A
- PHIO N/A
- Revenue This Year
- BACK N/A
- PHIO N/A
- Revenue Next Year
- BACK N/A
- PHIO N/A
- P/E Ratio
- BACK N/A
- PHIO N/A
- Revenue Growth
- BACK N/A
- PHIO N/A
- 52 Week Low
- BACK $1.00
- PHIO $2.17
- 52 Week High
- BACK $7.75
- PHIO $18.81
- Technical
- Relative Strength Index (RSI)
- BACK 35.53
- PHIO 32.01
- Support Level
- BACK $1.00
- PHIO $2.49
- Resistance Level
- BACK $1.35
- PHIO $3.70
- Average True Range (ATR)
- BACK 0.10
- PHIO 0.31
- MACD
- BACK -0.01
- PHIO -0.10
- Stochastic Oscillator
- BACK 5.68
- PHIO 2.75
About BACK IMAC Holdings Inc.
IMAC Holdings Inc is a provider and manager of value-based, conservative medical care combining life science advancements with traditional medical care for movement-restricting diseases and conditions in IMAC Regeneration Centers and BackSpace clinics. Its Innovative Medical Advancements and Care (IMAC) Regeneration Centers combine medical and physical procedures to improve patient experiences and outcomes and reduce healthcare costs as compared to other available treatment options.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.